RIASSUNTO. -Nel nucleo cellulare i trascritti primari dei geni subiscono varie modificazioni molecolari per diventare RNA maturi, pronti per essere esportati nel citoplasma. Questi eventi molecolari sono ordinati cronologicamente e spazialmente, e avvengono prevalentemente in strutture contenenti ribonucleoproteine (RNP). Difetti nella maturazione dell'RNA sono stati associati a patologie che provocano distrofia muscolare: nelle distrofie miotoniche di tipo 1 (DM1) e di tipo 2 (DM2), le caratteristiche multisistemiche (ad esempio, miotonia, distrofia muscolare, cardiomiopatia dilatativa, difetti della conduzione cardiaca, cataratta, insulino-resistenza, anomalie sierologiche specifiche) che contraddistinguono queste patologie sono causate dall'espansione di due distinte sequenze nucleotidiche ((CTG)n nel gene DMPK del cromosoma 19q13 nella DM1, e (CCTG)n nel gene ZNF9 del cromosoma 3q21 nella DM2). Associando tecniche biomolecolari e citochimiche, è stato dimostrato che i meccanismi di base in entrambe le DM consistono nel sequestro nucleare degli RNA espansi: i trascritti contenenti CUG e CCUG si accumulano in foci intranucleari rispettivamente nella DM1 e nella DM2, ed alterano la regolazione e la localizzazione intranucleare delle proteine CUGBP1 e MBLN1, necessarie per la maturazione fisiologica del pre-RNA messaggero (mRNA). Mediante tecniche immunocitochimiche in microscopia ottica ed elettronica, il nostro gruppo ha dimostrato che, nella DM2, i foci contenenti MBNL1 sequestrano anche snRNPs e hnRNPs, fattori di splicing coinvolti nelle fasi precoci della maturazione dei trascritti, a supporto dell'ipotesi che il fenotipo patologico multifattoriale dei pazienti distrofici sia dovuto ad una generale alterazione dei processi maturativi posttrascrizionali del pre-mRNA. Abbiamo anche dimostrato che, nei muscoli scheletrici di pazienti affetti da DM1 e DM2, diversi fattori di splicing e di cleavage si accumulano
nei mionuclei, suggerendo disfunzioni nei processi di maturazione del pre-mRNA simili alle alterazioni nucleari tipiche della sarcopenia (la perdita di massa e funzione muscolare che si verifica fisiologicamente con l'invecchiamento). Inoltre, in uno studio in vitro, abbiamo osservato che i mioblasti derivati da cellule satellite di pazienti affetti da DM2 mostrano caratteristiche tipiche della senescenza e disfunzioni dei processi maturativi del pre-mRNA più precocemente dei mioblasti di individui sani. Nel loro insieme, questi dati suggeriscono l'esistenza di meccanismi nucleari comuni alla base delle alterazioni muscolari in diverse condizioni patologiche. *** ABSTRACT. -In the cell nucleus, genes are transcribed, and the primary transcripts undergo molecular processing which generates mature RNAs to be exported to the cytoplasm. The events leading to the formation of mature RNAs are chronologically and spatially ordered, and they mostly occur on distinct ribonucleoprotein (RNP)-containing structures. Defects in the RNA maturation pathways have been related to diseases leading to muscle dystrophy: in myotonic dystrophy type 1 (DM1) and type 2 (DM2), the characteristic multisystemic features (e.g., myotonia, muscular dystrophy, dilated cardiomyopathy, cardiac conduction defects, cataracts, insulin-resistance, and disease-specific serological abnormalities) are caused by the expansion of two distinct nucleotide sequences: (CTG)n in the 3' untranslated region of the DMPK gene on chromosome 19q13 in DM1, and (CCTG)n in the first intron of the ZNF9 gene on chromosome 3q21 in DM2. Combining biomolecular and cytochemical techniques, it has been demonstrated that the basic mechanisms of both DMs reside in the nuclear sequestration of the expanded RNAs: CUG-and CCUG-containing transcripts accumulate in intranuclear foci in DM1 and DM2 cells respectively, and alter the regulation and intranuclear localization of the RNA-binding proteins CUGBP1 and MBLN, which are necessary for the physiological processing of pre-mRNA. Using immunocytochemical techniques at light and electron microscopy, we have demonstrated that MBNL1-containing foci in DM2 cells also sequester snRNPs and hnRNPs, splicing factors involved in the early phases of transcript processing; this strengthens the hypothesis that the multifactorial phenotype of dystrophic patients could be due to a general alteration of the pre-mRNA post-transcriptional pathway. Interestingly, we also demonstrated that, in skeletal muscles of DM1 and DM2 patients, splicing and cleavage factors accumulate in myonuclei, suggesting an impairment of pre-mRNA processing reminiscent of the nuclear alterations typical of sarcopenia (i.e. the loss of muscle mass and function physiologically occurring during ageing). Moreover, in an in vitro study, we observed that satellite-cell-derived DM2 myoblasts show cell senescence alterations and impairment of the pre-mRNA maturation pathways earlier than the myoblasts from healthy patient. These results suggest possible common cellular mechanisms responsible for skeletal muscle wasting in different pathologies.
CELL NUCLEAR ARCHITECTURE AND IN SITU ANALYSIS OF RNA PROCESSING
In eukaryotic cells, gene primary transcripts (pre-mRNAs) undergo extensive modifications before generating mature mRNA to be exported to the cytoplasm. This processing occurs in the spliceosome, a molecular complex composed by five small nuclear ribonucleoproteins (snRNPs) (U1, U2, U4/U6 and U5 snRNPs) and many nonsnRNP splicing factors as well as by a large number of regulating factors. After removal of introns, the maturation of 3' ends must be completed, and this requires the involvement of several cleavage and polyadenylation factors (Wahle and Rüegsegger, 1999) .
The events leading to the formation of mature mRNA occur mostly co-transcriptionally, thereby implying the simultaneous presence of different molecules on the transcriptional sites. The structural counterpart of these molecular complexes is represented by the perichromatin fibrils (PF), fine fibrillar structures mainly distributed at the edge of condensed chromatin (the so-called perichromatin region); PF represent the in situ form of nascent transcripts (reviews in Fakan, 1994 Fakan, , 2004 as well as of their splicing (Cmarko et al., 1999 ) and 3' end processing (Schul et al., 1996; Cardinale et al., 2007) . PF are therefore highly sensitive markers not only for monitoring the transcriptional and processing rate of a cell, but also for identifying the maturation level of (pre)mRNA occurring in the nucleus in functional correlation with the cellular metabolic state .
The pathways followed by the maturating pre-mRNA before to be exported to the cytoplasm are not completely known: it is likely that one part would migrate through the interchromatin space towards the nuclear pores as PF, while another part would be carried by the perichromatin granules (PG). These roundish RNP structures, preferentially occurring in the perichromatin region (Monneron and Bernhard, 1969) , would act as both vectors and storage sites of already spliced pre-mRNA (Fakan, 1994 (Fakan, , 2004 , and modifications in the number and/or molecular composition of PG are markers of alterations of the intranuclear pathways (e.g. Puvion et al., 1977; Puvion-Dutilleul and Puvion, 1981; Lafarga et al., 1993; Zancanaro et al., 1993) . The interchromatin granules (IG), occurring as clusters in the interchromatin space, represent storage, assembly and phosphorylation sites for transcription and splicing factors, but they are not directly involved in pre-mRNA modifications (Puvion and Puvion-Dutilleul, 1996; Bogolyubov et al., 2009) .
Therefore, the events leading to the formation of mature RNAs are chronologically and spatially ordered, and they mostly occur on distinct RNP-containing structures (Figure 1 ). The specific intranuclear location of these RNP components, clearly recognizable by the cytochemical EDTA technique (Bernhard, 1969) , is a necessary prerequisite for the correct processing of nuclear RNAs to occur, so that whenever transcription and/or splicing are altered, the organization, composition, and intranuclear location of RNP-containing structures are also affected (Biggiogera et al., 2004 Malatesta et al., 2008 Malatesta et al., , 2010a . As a consequence, the in situ analysis of the nuclear organization and molecular composition not only provides information about the DNA/RNA pathways which govern the cellular metabolism, but may reveal the occurrence of dysfunctions related to pathological phenotypes, also in skeletal muscle diseases (Malatesta and Meola, 2010) .
CELL NUCLEAR ALTERATIONS IN MYOTONIC DYSTROPHY
Myotonic dystrophies (DMs) are autosomal dominant disorders characterised by a variety of multisystemic features including muscular dystrophy with increased number of centrally located or clumped nuclei in muscle fibres (Vihola et al., 2003) , myotonia (muscle hyperexcitability), dilated cardiomyopathy, cardiac conduction defects (Bachinski et al., 2003) , insulin-resistance, cataracts (Meola and Moxley, 2004) , and disease-specific serological abnormalities (Savkur et al., 2001 (Savkur et al., , 2004 Day et al., 2003) . Two forms of DM are known: the more severe DM1-Steinert's disease (OMIM 160900) is caused by an expanded (CTG)n nucleotide sequence in the 3' untranslated region of the Dystrophia Myotonic Protein Kinase (DMPK) gene (OMIM 605377) on chromosome 19q13 (Brook et al., 1992; Fu et al., 1992; Mahadevan et al., 1992) ; the second form, DM2 (OMIM 602688) displays a milder clinical phenotype and is caused by the expansion of the tetranucleotidic repeat (CCTG)n in the first intron of the Zinc Finger Protein (ZNF)-9 gene (OMIM 116955) (Liquori et al. 2001) on chromosome 3q21 (Ranum et al., 1998) . (Bernhard, 1969) Defects in the RNA maturation pathways have been related to both DM forms. Combining biomolecular and cytochemical techniques, it has been demonstrated that the expanded-CUG-and CCUG-containing transcripts in DM1 and DM2 cells are retained in the cell nucleus, and accumulate in the form of focal aggregates (Liquori et al., 2001 ). These nuclear foci of mutant mRNA specifically sequester the alternative splicing regulators CUG-binding protein 1 (CUGBP1) and muscleblind-like 1 (MBLN1) protein (Miller et al., 2000; Ladd et al., 2001; Fardaei et al., 2002; Holt et al., 2009; Jones et al., 2011) , which are necessary for the physiological processing of pre-mRNA, especially for contractile protein synthesis (Llorian and Smith, 2011) . The sequestration into foci leads to nuclear depletion and loss of function of these important factors (Mankodi et al., 2001) . These focal aggregates are considered as a biomolecular feature of DMs, and have been detected in several adult tissues and cell cultures by in situ hybridization (Taneja et al., 1995; Liquori et al., 2001; Mankodi et al., 2003 Mankodi et al., , 2005 Cardani et al., 2004 Cardani et al., , 2006 Cardani et al., , 2009 Schoser et al., 2004; Wheeler and Thornton, 2007) . The molecular composition of nuclear foci is far from being fully elucidated. Our group, by combining immunofluorescence and immunoelectron microscopy on cultured myoblasts from DM patients, has demonstrated that foci also sequester hnRNPs and snRNPs, i.e. splicing factors involved in the early phases of the pre-mRNA processing (Figures 2 and  3) . The sequestration of these splicing factors strengthens the hypothesis that the multifactorial phenotype of dystrophic patients could be due to a general alteration of the pre-mRNA post-transcriptional pathway. 
. The immunolabelling for MBNL1 (red fluorescence in a) and that for the hnRNP core protein (green fluorescence in b) frequently co-locate (yellow fluorescence in the merged image, c). In the insets in panel c), the co-labelled foci indicated by the arrows are shown at a higher magnification. In panel a), the counterstaining with Hoechst 33258 of nuclear DNA is also shown (blue fluorescence). Bar: 10 µm.
In a very recent study, by using biochemical, immunocytochemical and morphometric techniques, we investigated the fate of MBNL1-containing foci in proliferating and in non-cycling cultured skin fibroblasts from DM2 patients (Giagnacovo et al., 2012) . We demonstrated that MBNL1 associates to the transcribed RNA expanded sequences and accumulate in the nuclear foci during interphase; at mitosis, the foci relocate to the cytoplasm where they remain until the following early G1, when cytoplasmic foci undergo degradation; at the same time, newlyformed foci develop in the nucleus as a consequence of de novo accumulation of expanded RNAs. In DM2 proliferating fibroblasts, the cyclic release from the nucleus of the foci and their cytoplasmic degradation actually prevent a massive intranuclear sequestration of MBNL1 and other protein factors involved in pre-mRNA processing. On the contrary, when fibroblasts loose their proliferation capabilities and stop cycling, the nuclear foci do not undergo relocation/degradation and undergo progressive increase in number and size, due to a continuous accumulation of both expanded RNAs and protein factors among which MBNL1. Interestingly, measurements on muscle biopsies taken from the same DM2 patients at different ages demonstrated that, in the nuclei of myofibres, the MBNL1-containing foci become larger with increasing patient's age (Giagnacovo et al., 2012) .
This dynamic behaviour of nuclear foci is compatible with the evidence that in DM patients the most affected organs or tissues are those where non-renewing cells are mainly present, such as the skeletal muscle, heart and the central nervous system, whereas cells from self-renewing tissues (such as skin fibroblasts or layering epithelial cells) are much less affected.
In addition to the formation of intranuclear foci, DM1 and DM2 cells show an altered distribution of nuclear RNP-containing structures and molecular factors responsible for pre-mRNA transcription and maturation. In particular, by means of ultrastructural immunocytochemistry on skeletal muscle biopsies from DM1 and DM2 patients, we have recently demonstrated (Malatesta et al., 2011b ) that splicing and cleavage factors accumulate in the intranuclear functional sites where they are usually located (i.e., hnRNPs and CStF on PF; snRNPs on PF and IG) (Figure 4) . Accordingly, new results on the intranuclear distribution of MBNL1 in myonuclei of skeletal muscle from DM1 and DM2 patients revealed an accumulation of this alternative splicing factor on PF and also on IG (where it does not usually occur in healthy subjects) (Malatesta et al., manuscript in preparation) . This accumulation could hamper the functionality of the splicing machinery and slow down the intranuclear molecular trafficking thus reducing the metabolic activity of myonuclei, consistent with recent findings demonstrating a reduced protein synthesis in DM1 and DM2 myoblasts (Salisbury et al., 2009; Huichalaf et al., 2010) . 
MYOTONIC DYSTROPHY AND AGEING: COMMON MECHANISMS FOR SIMILAR EFFECTS?
Ageing is associated with a progressive loss of muscle mass, strength and function, known as sarcopenia (Ryall et al., 2008; Thompson, 2009; Cruz-Jentoft et al., 2011) . Interestingly, under this condition the skeletal muscle is characterized by grouped atrophy, fiber size variability and centrally located nuclei (Endstrom et al., 2007) , similarly to muscles affected by DM. In addition, some cell nuclear alterations described in myofibres of sarcopenic muscles are reminiscent of those found in DM cells. In fact, although no foci have been observed, factors involved in pre-mRNA post-transcriptional processing have been found to accumulate on PF and, sometimes, to move to IG, where they do not usually locate (Malatesta et al., , 2010b (Malatesta et al., , 2011a . This intranuclear accumulation/delocalization of RNP structures containing splicing and cleavage factors has been found not only in aged skeletal muscle but also in other tissues (e.g., liver, brain) from old rodents (Malatesta et al., 2003 (Malatesta et al., , 2005 (Malatesta et al., , 2007 (Malatesta et al., , 2010a BertoniFreddari et al., 2004) . This suggests that in ageing cells the entire production chain of mRNA, from synthesis to cytoplasmic export, becomes less efficient, likely contributing to the reduced cell responsiveness to metabolic stimuli which is typical of elderly. This loss of responsiveness would be particularly serious in skeletal muscle cells, where a misregulated protein turnover would result in a structural imbalance between muscle protein synthesis and degradation (review in Koopman, 2009) .
In a recent study (Malatesta et al., 2011c) we investigated in vitro the structural and functional features of satellite-cell-derived myoblasts and we observed that DM2 myoblasts show cell-senescence alterations such as cytoplasmic vacuolisation, reduction of the proteosynthetic apparatus, accumulation of heterochromatin and impairment of the pre-mRNA maturation pathways earlier than myoblasts from healthy patients ( Figures 5 and 6) ; moreover, DM2 myoblasts generate myotubes characterised by structural defects similar to senescent healthy myotubes (Giagnacovo et al., 2011) . The early occurrence of senescence-related features in satellite cellderived myoblasts would therefore reduce the regeneration capability of DM2 satellite cells, thus contributing to the muscular dystrophy in DM2 patients. (a, a' and b, b') and DM2 patients (c, c' and d, d') 
CONCLUDING REMARKS
Based on the cytochemical and ultrastructural evidence, the skeletal muscle of DM patients seems to share intriguing similarities with the muscle from aged mammals, with special reference to the alterations in the nuclear RNP-containing structures involved in pre-mRNA transcription and splicing. This opens interesting perspectives on the role of the RNP nuclear components in the onset of muscle cell dysfunctions and encourages comparative studies aimed at detecting common cellular mechanisms at the basis of skeletal muscle wasting.
